Wearing-off at the end of natalizumab dosing interval and...

Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study

Bringeland, Gerd Haga, Myhr, Kjell-Morten, Vedeler, Christian Alexander, Gavasso, Sonia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
415
Journal:
Journal of the Neurological Sciences
DOI:
10.1016/j.jns.2020.116880
Date:
August, 2020
File:
PDF, 161 KB
2020
Conversion to is in progress
Conversion to is failed